Trial of IW-9179 in Patients With Diabetic Gastroparesis (DGP)
NCT02289846 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2016-12-05
Summary
The objectives of this study are to evaluate the safety of IW-9179 in patients with diabetic gastroparesis (DGP) and the effect of treatment on the cardinal symptoms of DGP.
Conditions
- Diabetic Gastroparesis
Interventions
- DRUG
-
IW-9179
- DRUG
-
Matching Placebo
Sponsors & Collaborators
-
Ironwood Pharmaceuticals, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United States
Study Locations
More Related Trials
-
A Scintigraphy Study in Adults With Diabetic Gastroparesis
NCT04208698 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of CNSA-001 in Women With Diabetic Gastroparesis
NCT03712124 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis Participants
NCT03281577 ·Status: COMPLETED ·Phase: PHASE2
-
The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes
NCT04228484 ·Status: COMPLETED ·Phase: NA
-
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
NCT02170870 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Dasiglucagon for Treatment of Post-bariatric Hypoglycemia in Roux-en-Y Gastric Bypass (RYGB) Operated Adults
NCT04824872 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Diagnostic Methods and Dietary Treatment of Diabetic Gastroparesis
NCT01557296 ·Status: COMPLETED ·Phase: PHASE2
-
Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176890 ·Status: UNKNOWN ·Phase: NA
-
A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus
NCT00437164 ·Status: TERMINATED ·Phase: PHASE2
-
Drug Trial of Lixisenatide on Gastric Emptying and Blood Pressure Drops in Type 2 Diabetics and Healthy People
NCT02308254 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis
NCT00390975 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects
NCT03682172 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
GLP-1 and Hypoglycemia
NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
NCT04965051 ·Status: UNKNOWN ·Phase: NA
-
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus
NCT01919684 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Domperidone (a Prokinetic Agent) on Time in Range in Digestively Asymptomatic Type I Diabetic Patients With Delayed Gastric Emptying (Gastro-TIR)
NCT06695962 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus.
NCT02225951 ·Status: TERMINATED ·Phase: NA
-
Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176760 ·Status: UNKNOWN ·Phase: NA
-
Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
NCT04449692 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Glucose-Dependent Insulinotropic Polypeptide in the Pathological Glucose Homeostasis Of Type 1 Diabetes
NCT03734718 ·Status: COMPLETED ·Phase: NA
-
GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide
NCT03845179 ·Status: COMPLETED ·Phase: NA
-
A Study of the Effect of Taspoglutide on Gastric Emptying in Patients With Type 2 Diabetes
NCT00809705 ·Status: COMPLETED ·Phase: PHASE3
-
Early Diabetes Intervention Program
NCT01470937 ·Status: COMPLETED ·Phase: PHASE4
-
Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass
NCT05057819 ·Status: COMPLETED ·Phase: PHASE4